Secondary Logo

Institutional members access full text with Ovid®

1623

EFFECT OF ANGIOTENSIN II ON VASOPRESSOR DOSE AND SAFETY IN PATIENTS WITH SEVERE VASODILATORY SHOCK

Ferrada, Paula1; Strumwasser, Aaron2; Zarbock, Alexander3; Mackey, Caleb4; Wilkinson, Jonny5; Handisides, Damian6; Prowle, John7

doi: 10.1097/01.ccm.0000552364.69876.25
Research Snapshot Theater: Sepsis IX
Buy

1Virginia Commonwealth University School of Medicine, Richmond, VA

2Los Angeles County USC Medical Center, Los Angeles, CA

3University Hospital Munster, Munster, Germany

4Riverside Pulmonary Association, Columbus, OH

5Northampton General Hospital, Northampton, United Kingdom

6La Jolla Pharmaceutical Company, San Diego, CA

7Barts and the London School of Medicine and Dentistry, London, United Kingdom

Copyright © by 2019 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.